why choose us

First received: February 03, 2023

Clinical Trial: Study of Obeldesivir in Nonhospitalized Participants With COVID-19

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5245 for the Treatment of COVID-19 in Nonhospitalized Participants

Brief Summary: The goal of this clinical study is to test if obeldesivir (formerly GS-5245) is safe and effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a standard risk of developing severe illness.This study will also measure how much obeldesivir gets into the blood and how long it takes for the body to get rid of it.

Read more